Webinar: Decreasing Patient Burden Without Increasing Site Burden
Wednesday, January 18, 2023 | 11:00am – 12:00pm EST
How do we address challenges from every stakeholder in the ecosystem?
There are an increasing number of clinical trials being conducted which leads to an increasing need for patients and investigative site staff to participate. Early research has shown that decentralized clinical trials (DCTs) can be beneficial for patients. The hypothesis was that implementing DCTs would also benefit sites; however, experience has shown that DCTs can present some challenges for sites.
In this webinar, we will highlight the current state of the industry as it relates to DCT usage, the opportunities and challenges and how the ecosystem can work together to alleviate the site burdens that come along with DCT implementation.
What specific valuable things will viewers learn or gain?
Crissy MacDonald, PhD
Vice President, Client Delivery
As the leader of WCG Avoca’s integrated consulting and research solutions, Cristin MacDonald provides consulting services to top pharmaceutical, biotech, and contract research organizations, and oversees client deliverables, systems, and processes across Avoca.
Crissy has over 15 years of pharmaceutical industry experience with expertise in clinical research, process development, and strategic management. Her previous professional roles have touched every stage of the clinical trials process, from pre-clinical research through late-stage clinical development.
Crissy earned a Ph.D. in biomedical engineering from Drexel University and a bachelor’s degree from Lafayette College.
Global Site Success Adoption Lead
Annie has worked in the clinical research industry for over 20 years. She started out in the industry in South Africa as a nurse/site coordinator, moving into the clinical research industry as a site monitor working for Bayer, prior to moving to the UK in 1999.
Over the years Annie has worked in various roles in the industry covering all phases of clinical research (from phase I – IV) specializing in a wide range of therapeutic areas. Annie has had the opportunity to work for both Pharma companies (Bayer, Schering-Plough and Shire) and various CROs including, ICON, PPD, Pharma Olam and recently for Covance.
Prior to Medable, Annie successfully lead and built up the Clinical Team Leads at Covance where she was key in expanding the group in Europe to a Globally lead group, focused on Client delivery and excellence in quality.
In her role at Medable, Annie has built up a global Site Adoption Team aimed at supporting clients, sites and internal teams in order to ensure a seamless adoption of technology.